Piperlongumine
Piperlongumine (Piplartine) · also known as Piperlongumine, Piplartine, Piplartine
In cell experiments, piperlongumine can preferentially kill some senescence-induced cells, and its target is still under study. Selective clearance in humans has not been confirmed, and no validated oral pulse regimen exists.
Mechanisms of action
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In mice, intraperitoneal piperlongumine can suppress NF-κB signaling in the brain after an inflammatory stimulus, which is a different exposure from oral supplementation. No reliable study has examined whether it suppresses the inflammatory factors secreted by senescent cells (SASP) in humans.
Apoptosis-driven clearance of senescent cells (senolytic activity)
In some senescent-cell experiments, piperlongumine can preferentially kill senescent cells, and related studies suggest that OXR1, among other factors, may be involved. The mechanism and specific targets of selective clearance are not yet fully established, and there is no reliable study of clearance in humans after oral intake.